Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy
Cells · 08.11.2026 · 15 (21) · 2035
DOI: 10.3390/cells15212035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 08.11.2026. Verfasst von Estera Okoń und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Histone Acetyltransferases, Epigenesis, Genetic, Histone Deacetylases, Neoplasms. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigenetic dysregulation constitutes a fundamental molecular hallmark of oncogenesis, arising from aberrant alterations in chromatin architecture and transcriptional regulation that disrupt cellular differentiation, sustain malignant phenotypes, promote therapeutic resistance, and facilitate tumor initiation and progression. Among the principal epigenetic mechanisms, histone acetylation is dynamically regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), making these enzymes attractive targets for pharmacological intervention. Although several synthetic epigenetic drugs have entered clinical practice, their therapeutic utility may be constrained by limited selectivity, toxicity, and adaptive resistance, prompting the continued investigation of structurally diverse natural compounds. The review examines comparatively underexplored plant-derived phytochemicals with reported or proposed HAT- and/or HDAC-modulatory properties, focusing on parthenolide, anacardic acid, formononetin, plumbagin, and allicin and its derivatives, including S-allylmercaptocysteine (SAMC). The available evidence indicates that these compounds can influence epigenetic processes through distinct, pleiotropic, mechanisms, potentially affecting cellular proliferation, apoptosis, differentiation, and responses to anticancer treatment. Collectively, these findings support the further investigation of cryptic plant-derived HAT/HDAC modulators as candidate epigenetic adjuvants, while underscoring the need for rigorous mechanistic validation, pharmacokinetic characterization, and translational assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland.
- Department of Pharmacognosy with Medicinal Plants Garden, Medical University of Lublin, 1 Chodzki Str., 20-093 Lublin, Poland.
- Department of Food and Nutrition, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.
- Department of Medical Chemistry, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.
ORCID-Profile: Estera Okoń, Wirginia Kukula-Koch, Joanna Tokarczyk, Wojciech Koch, Anna Wawruszak
Zitieren
APA
Okoń, E., Jarząb, A., Kukula-Koch, W., Tokarczyk, J., Koch, W., Boguszewska-Czubara, A., & Wawruszak, A. (2026). Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy. Cells, 15(21), 2035. https://doi.org/10.3390/cells15212035
Vancouver
Okoń E, Jarząb A, Kukula-Koch W, Tokarczyk J, Koch W, Boguszewska-Czubara A, et al. Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy. Cells. 2026;15(21):2035. doi:10.3390/cells15212035
BibTeX
@article{Oko2026,
author = {Okoń, Estera and Jarząb, Agata and Kukula-Koch, Wirginia and Tokarczyk, Joanna and Koch, Wojciech and Boguszewska-Czubara, Anna and Wawruszak, Anna},
title = {Beyond the Well-Known Phytochemicals: Cryptic Plant-Derived Histone Acetyltransferase (HAT) and Histone Deacetylase (HDAC) Modulators as Epigenetic Adjuvants in Cancer Therapy},
journal = {Cells},
year = {2026},
volume = {15},
number = {21},
pages = {2035},
doi = {10.3390/cells15212035}
}
EUVIMED